AllergoOncology: ultra-low IgE, a potential novel biomarker in cancer-a Position Paper of the European Academy of Allergy and Clinical Immunology (EAACI). (2020)
Attributed to:
Preclinical efficacy of an antibody of the IgE class against a melanoma-associated antigen
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1186/s13601-020-00335-w
PubMed Identifier: 32695309
Publication URI: http://europepmc.org/abstract/MED/32695309
Type: Journal Article/Review
Volume: 10
Parent Publication: Clinical and translational allergy
ISSN: 2045-7022